Skip to content

FDA

  • Lilly’s New Obesity Drug Shows 28% Weight Loss in Late-Stage Trial

    22.05
  • Expert Panel Sets First Clear Definition for Ultra-Processed Foods

    21.05
  • Peptide Therapy Market Hits $46 Billion as AI Transforms Drug Discovery

    19.05
  • Common Pesticide More Than Doubles Parkinson’s Risk, UCLA Study Finds

    15.05
  • New Pancreatic Cancer Drugs Triple Survival Time in Clinical Trials

    12.05
  • Cancer Warning Labels on Alcohol Cut Drinking in National Study

    08.05
  • Genetics Explain Why Ozempic Works Better for Some People Than Others

    07.05
  • Metabolic Liver Disease Cases Rise 50% in 30 Years as FDA Approves First Treatment

    06.05
  • Hantavirus Outbreak Kills 3 on Atlantic Cruise Ship, WHO Confirms

    04.05
  • FDA Restricts Popular Men’s Health Peptides as $140 Billion Market Faces Regulatory Shakeup

    29.04
Next Page
    • About

The content published in Morning Healthwire is for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making any decisions about your health, medications, diet, or fitness routine.

Designed with WordPress

Loading Comments...